Acceleration

NFPrompt Participates in NVIDIA's Developer Program: Unleashing the Future of AI-Powered NFT Creation

Retrieved on: 
Tuesday, March 12, 2024

This collaboration marks a significant leap forward for NFPrompt, empowering it to deliver even more powerful and accessible AI tools to its passionate user base.

Key Points: 
  • This collaboration marks a significant leap forward for NFPrompt, empowering it to deliver even more powerful and accessible AI tools to its passionate user base.
  • As a pioneer in the convergence of AI and Web3 (decentralized web), NFPrompt recognizes the immense potential of NVIDIA's cutting-edge technology.
  • NFPrompt Cofounder Sparks perfectly captures the company's enthusiasm: "We are thrilled to join the NVIDIA Developer Program.
  • This partnership will be instrumental in propelling NFPrompt to the forefront of AI-powered NFT creation.

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Amplitude, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMPL

Retrieved on: 
Saturday, March 9, 2024

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles.

Key Points: 
  • WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

ME Therapeutics Announces Closing of Non-Brokered Private Placement

Retrieved on: 
Wednesday, March 6, 2024

Vancouver, British Columbia--(Newsfile Corp. - March 6, 2024) - ME Therapeutics Holdings Inc. (CSE: METX) (FSE: Q9T) ("ME Therapeutics" or the "Company"), a preclinical stage biotechnology company working on novel cancer fighting drugs in the field of Immuno-Oncology, announces the closing of its previously announced non-brokered private placement financing (the "Offering") and has issued 1,555,000 units (each, a "Unit") at a price of $1.00 per Unit raising gross proceeds of $1,555,000.

Key Points: 
  • Vancouver, British Columbia--(Newsfile Corp. - March 6, 2024) - ME Therapeutics Holdings Inc. (CSE: METX) (FSE: Q9T) ("ME Therapeutics" or the "Company"), a preclinical stage biotechnology company working on novel cancer fighting drugs in the field of Immuno-Oncology, announces the closing of its previously announced non-brokered private placement financing (the "Offering") and has issued 1,555,000 units (each, a "Unit") at a price of $1.00 per Unit raising gross proceeds of $1,555,000.
  • Each Unit is comprised of one common share of the Company (each, a "Share") and one Share purchase warrant (each, a "Warrant").
  • All securities issued in connection with the Offering are subject to a statutory hold period expiring four months and one day after the date of the Closing.
  • No finder's fees were paid in connection with the Offering.

Cosa Resources Closes C$6.5 Million Private Placement

Retrieved on: 
Tuesday, March 5, 2024

Vancouver, British Columbia--(Newsfile Corp. - March 5, 2024) - Cosa Resources Corp. (TSXV: COSA) (OTCQB: COSAF) (FSE: SSKU) ("Cosa" or the "Company") is pleased to announce that it has closed the brokered private placement previously announced by the Company on February 12, 2024, as upsized on February 13, 2024, for aggregate gross proceeds of C$6,500,816 (the "Offering").

Key Points: 
  • Vancouver, British Columbia--(Newsfile Corp. - March 5, 2024) - Cosa Resources Corp. (TSXV: COSA) (OTCQB: COSAF) (FSE: SSKU) ("Cosa" or the "Company") is pleased to announce that it has closed the brokered private placement previously announced by the Company on February 12, 2024, as upsized on February 13, 2024, for aggregate gross proceeds of C$6,500,816 (the "Offering").
  • The Offering was completed through a syndicate of underwriters, led by Haywood Securities Inc. and including PI Financial Corp. (collectively, the "Underwriters").
  • All Qualifying Expenditures will be renounced in favour of the subscribers of the Charity FT Units effective December 31, 2024.
  • Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

Stamper Oil & Gas Corp.: Corporate Update

Retrieved on: 
Tuesday, March 5, 2024

Vancouver, British Columbia--(Newsfile Corp. - March 5, 2024) - Stamper Oil & Gas Corp. (TSXV: STMP) (FSE: TMP2) ("Stamper" or the "Company") Is pleased to provide a spring corporate update from our President and CEO Bryson Goodwin.

Key Points: 
  • Vancouver, British Columbia--(Newsfile Corp. - March 5, 2024) - Stamper Oil & Gas Corp. (TSXV: STMP) (FSE: TMP2) ("Stamper" or the "Company") Is pleased to provide a spring corporate update from our President and CEO Bryson Goodwin.
  • Comments from President and CEO Bryson Goodwin;
    I would like to thank shareholders who redeemed their warrants and increased their individual share positions.
  • The support demonstrated through those redemptions is appreciated and serves to fortify management and staff to continue with our efforts.
  • The impressive and endorsing results demonstrated at Redonda have management and advisors taking a committed approach to continued exploration and development.

ME Therapeutics Announces Non-Brokered Private Placement and Provides Corporate Update

Retrieved on: 
Tuesday, February 27, 2024

The Company confirms that the Offering Price was reserved confidentially on January 31, 2024 pursuant to section 6.2(4) of Policy 6 of the Canadian Securities Exchange (the "Exchange").

Key Points: 
  • The Company confirms that the Offering Price was reserved confidentially on January 31, 2024 pursuant to section 6.2(4) of Policy 6 of the Canadian Securities Exchange (the "Exchange").
  • Each Unit will be comprised of one common share of the Company (each, a "Share") and one Share purchase warrant (each, a "Warrant").
  • Completion of the Offering remains subject to certain conditions, including confirmation of no objection from the Exchange.
  • The Company continues to pursue research and development of its G-CSF antibody candidate, myeloid prodrug candidate and novel LNP formulation as previously disclosed in the Company's corporate update news release dated January 25, 2024.

GWM TANK 700 Hi4-T Launched in Beijing, Shaping a New Standard for Off-Road Flagship Vehicles

Retrieved on: 
Tuesday, February 27, 2024

The GWM TANK 700 Hi4-T perfectly represented the outstanding mechanical and exterior design.

Key Points: 
  • The GWM TANK 700 Hi4-T perfectly represented the outstanding mechanical and exterior design.
  • The GWM TANK 700 Hi4-T is designed to become a top-class luxury off-road vehicle, striking a perfect balance between off-road capability and comfort.
  • The GWM TANK 700 Hi4-T is equipped with ultra-wide-angle Light Cloud seats, ensuring ultimate comfort while driving, and setting an industry standard.
  • Through the multi-dimensional introduction throughout the conference, GWM comprehensively and deeply demonstrated the powerful and reliable performance of the GWM TANK 700 Hi4-T and its outstanding product strength.

ROSEN, A TOP RANKED LAW FIRM, Encourages Amplitude, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AMPL

Retrieved on: 
Monday, March 11, 2024

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles.

Key Points: 
  • WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

Most powerful series-production Porsche of all time sets record lap times at Laguna Seca and the Nürburgring; the Taycan Turbo GT and Taycan Turbo GT with Weissach Package

Retrieved on: 
Monday, March 11, 2024

In the Taycan Turbo GT and the Taycan Turbo GT with Weissach Package in particular, our engineers have achieved this in stunning fashion.

Key Points: 
  • In the Taycan Turbo GT and the Taycan Turbo GT with Weissach Package in particular, our engineers have achieved this in stunning fashion.
  • The Taycan Turbo GT and Taycan Turbo GT with Weissach Package are the new sporting flagship models and take Taycan performance to the next level.
  • The Taycan Turbo GT features the Sport Chrono package from the Taycan Turbo S.
    Designed for performance on the track: Taycan Turbo GT with Weissach Package
    The Taycan Turbo GT with optional Weissach Package is even more laser sharp in its positioning.
  • The Manufacturer’s Suggested Retail Price (MSRP) for the 2025 Taycan Turbo GT and the Taycan Turbo GT with Weissach Package start at $230,000.

AMPLITUDE, INC. (NASDAQ: AMPL) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Amplitude, Inc.

Retrieved on: 
Monday, March 11, 2024

If you purchased or acquired Amplitude common stock, and/or would like to discuss your legal rights and options please visit Amplitude, Inc.

Key Points: 
  • If you purchased or acquired Amplitude common stock, and/or would like to discuss your legal rights and options please visit Amplitude, Inc.
  • If you wish to serve as lead plaintiff, you must move the Court no later than April 15, 2024.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.